These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 2113479)

  • 1. Production and regulation of interleukin 6 in human B lymphoid cells.
    Hutchins D; Cohen BB; Steel CM
    Eur J Immunol; 1990 May; 20(5):961-8. PubMed ID: 2113479
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lymphokine-activated effector cells: modulation of activity by cytokines.
    Mehta S; Flanagan P; Blackinton D; Wanebo H
    Lymphokine Cytokine Res; 1992 Apr; 11(2):73-7. PubMed ID: 1581419
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IgE production by normal human B cells induced by alloreactive T cell clones is mediated by IL-4 and suppressed by IFN-gamma.
    Pène J; Rousset F; Brière F; Chrétien I; Paliard X; Banchereau J; Spits H; De Vries JE
    J Immunol; 1988 Aug; 141(4):1218-24. PubMed ID: 3135324
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of recombinant IL-4, IFN-alpha, and IFN-gamma on the production of human IgE-binding factor (soluble CD23).
    Delespesse G; Sarfati M; Peleman R
    J Immunol; 1989 Jan; 142(1):134-8. PubMed ID: 2521231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IL-4 induces LFA-1 and LFA-3 expression on Burkitt's lymphoma cell lines. Requirement of additional activation by phorbol myristate acetate for induction of homotypic cell adhesions.
    Rousset F; Billaud M; Blanchard D; Figdor C; Lenoir GM; Spits H; De Vries JE
    J Immunol; 1989 Sep; 143(5):1490-8. PubMed ID: 2547869
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunomodulatory role of IL-4 on the secretion of Ig by human B cells.
    Splawski JB; Jelinek DF; Lipsky PE
    J Immunol; 1989 Mar; 142(5):1569-75. PubMed ID: 2493049
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of hepatocyte growth factor/scatter factor by interferon-gamma in human leukemia cells.
    Gohda E; Takebe T; Sotani T; Nakamura S; Minowada J; Yamamoto I
    J Cell Physiol; 1998 Jan; 174(1):107-14. PubMed ID: 9397161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro transformation by Epstein-Barr virus induces a switch in growth factor and anti-IgM responsiveness in a human leukemic B cell clone.
    Janssen O; Gillis S; Kabelitz D
    Eur J Immunol; 1990 Jan; 20(1):7-14. PubMed ID: 2155117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancement of human B cell proliferation and differentiation by tumor necrosis factor-alpha and interleukin 1.
    Jelinek DF; Lipsky PE
    J Immunol; 1987 Nov; 139(9):2970-6. PubMed ID: 3117883
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of germ-line epsilon transcription and induction of epsilon switching in cloned EBV-transformed and malignant human B cell lines by cytokines and CD4+ T cells.
    Gauchat JF; Gascan H; de Waal Malefyt R; de Vries JE
    J Immunol; 1992 Apr; 148(7):2291-9. PubMed ID: 1347554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombinant IL 2 but not recombinant interferon-gamma stimulates both proliferation and IgM secretion in a Ly-1+ clone of neoplastic murine B cells (BCL1).
    Brooks KH; Vitetta ES
    J Immunol; 1986 Nov; 137(10):3205-10. PubMed ID: 2945863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and biological effects of intraperitoneal injections of recombinant interferon-gamma and recombinant interleukin 2 with or without tumor-infiltrating lymphocytes in patients with ovarian or peritoneal carcinoma.
    Freedman RS; Kudelka AP; Kavanagh JJ; Verschraegen C; Edwards CL; Nash M; Levy L; Atkinson EN; Zhang HZ; Melichar B; Patenia R; Templin S; Scott W; Platsoucas CD
    Clin Cancer Res; 2000 Jun; 6(6):2268-78. PubMed ID: 10873077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytokine production by T-cell lines derived from tumor-infiltrating lymphocytes from patients with ovarian carcinoma: tumor-specific immune responses and inhibition of antigen-independent cytokine production by ovarian tumor cells.
    Kooi S; Freedman RS; Rodriguez-Villanueva J; Platsoucas CD
    Lymphokine Cytokine Res; 1993 Dec; 12(6):429-37. PubMed ID: 8123759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymphotoxin acts as an autocrine growth factor for Epstein-Barr virus-transformed B cells and differentiated Burkitt lymphoma cell lines.
    Gibbons DL; Rowe M; Cope AP; Feldmann M; Brennan FM
    Eur J Immunol; 1994 Aug; 24(8):1879-85. PubMed ID: 8056047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Four cell-secreted cytokines act synergistically to maintain long term proliferation of human B cell lines in vitro.
    Abken H; Fluck J; Willecke K
    J Immunol; 1992 Oct; 149(8):2785-94. PubMed ID: 1328386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stimulation of EBV-activated human B cells by monocytes and monocyte products. Role of IFN-beta 2/B cell stimulatory factor 2/IL-6.
    Tosato G; Gerrard TL; Goldman NG; Pike SE
    J Immunol; 1988 Jun; 140(12):4329-36. PubMed ID: 2836512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Downregulation of phorbol 12-myristate 13-acetate-induced tumor necrosis factor-alpha and interleukin-1 beta production and gene expression in human monocytic cells by human alpha-fetoprotein.
    Wang W; Alpert E
    Hepatology; 1995 Sep; 22(3):921-8. PubMed ID: 7544757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IFN-beta 2, B cell differentiation factor 2, or hybridoma growth factor (IL-6) is expressed and released by human epidermal cells and epidermoid carcinoma cell lines.
    Kirnbauer R; Köck A; Schwarz T; Urbanski A; Krutmann J; Borth W; Damm D; Shipley G; Ansel JC; Luger TA
    J Immunol; 1989 Mar; 142(6):1922-8. PubMed ID: 2784142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heterogeneity in both cytokine production and responsiveness of a panel of monoclonal human Epstein-Barr virus-transformed B-cell lines.
    Jochems GJ; Klein MR; Jordens R; Pascual-Salcedo D; van Boxtel-Oosterhof F; van Lier RA; Zeijlemaker WP
    Hum Antibodies Hybridomas; 1991 Apr; 2(2):57-64. PubMed ID: 1651786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IL-6 is a potent cofactor of IL-1 in IgM synthesis and of IL-5 in IgA synthesis.
    Kunimoto DY; Nordan RP; Strober W
    J Immunol; 1989 Oct; 143(7):2230-5. PubMed ID: 2789259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.